News & Events

FEBRUARY 22, 2022

Rockland Immunochemicals, Inc. collaborates with Jefferson Institute for Bioprocessing to offer complete bioprocessing solutions

Rockland Immunochemicals, Inc. (Rockland) and the Jefferson Institute for Bioprocessing (JIB) announced today that an agreement has been signed under which both entities are able to utilize one another's strengths to provide complete and scalable bioprocessing solutio...

FEBRUARY 10, 2022

Rockland Immunochemicals, Inc. announces acquisition of antibodies-online GmbH and investment from BroadOak Capital Partners

With its acquisition of antibodies-online GmbH, Rockland expands its capabilities, product portfolio, and geographic footprint to serve scientists engaged in the discovery, development, and delivery of complex therapies and critical diagnostics ...

OCTOBER 18, 2021

Rockland expands infectious disease portfolio with new partner, Diagnostic BioSystems

Diagnostic BioSystems (DBS), a provider of cutting-edge in vitro diagnostics and high quality Immunohistochemistry (IHC) reagents has signed a distribution agreement with Rockland Immunochemicals, Inc ...

SEPTEMBER 28, 2021

From Philadelphia to Saudi Arabia: A partnership in support of biotech expansion

Rockland President and Chief Executive Officer, James Fendrick and the King Abdullah International Medical Research Center (ك KAIMRC) recently signed a Memorandum ...

SEPTEMBER 9, 2020

Unique Scientific-Academic Partnership Advances Revolutionary CRISPR in a Box™ Educational Gene Editing Kit

Introducing CRISPR in a Box - it is not a new crunchy cereal or the latest snack - it is an educational tool kit consisting of state-of-the-science gene editing technology that could be coming to a school near you ...

AUGUST 12, 2020

Rockland Employees Working on COVID-19 Antibody Development Featured in Recent Article by Montgomery County Community College

Rockland greatly values our local partnerships-one in particular is our partnership with Montgomery County Community College (MCCC) and their Biotechnology Associate Professor and Program Coordinator, Dr. Margaret Bryans ...

Rockland Develops Antibody Proven to Detect SARS-CoV-2 in Patient Samples

Rockland Immunochemicals Inc. has developed a critical antibody reagent essential to antibody tests used to determine SARS-CoV-2 exposure for patients suspected to have contracted COVID-19 ...

COVID-19: An Important Update

At Rockland, we are adjusting our business operations to account for the coronavirus (COVID-19) pandemic. We want you, our customers, to know our plans ...

Load More